Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (401-410 of 1,058) with videos related to

Pageof 106
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activityJ C Byrd, C A White, B Link, et al.
Hematology/Oncology Clinics of North America|August 25, 2004
Antibody therapy for chronic lymphocytic leukemia: a promising new modalityThomas S Lin, Mollie Moran, Margaret Lucas, et al.
The Biochemical Journal|June 15, 1991
Differential mucin gene expression in human pancreatic and colon cancer cellsS Yonezawa, J C Byrd, R Dahiya, et al.
British Journal of Haematology|July 21, 2018
Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centreKerry A Rogers, Ying Huang, Emily Dotson, et al.
Molecular Cell|July 6, 2000
M6P/IGF2R imprinting evolution in mammalsJ K Killian, J C Byrd, J V Jirtle, et al.
Leukemia|April 4, 2017
PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatmentD Jones, J A Woyach, W Zhao, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Examination of the Impact of Triazole Position within Linkers on Solubility and Lipophilicity of a CDK9 Degrader SeriesOluwatosin R Ayinde, Chia Sharpe, Emily Stahl, et al.
Cancer|May 15, 2018
Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemiaBarbara L Andersen, Neha Godiwala Goyal, David M Weiss, et al.
Journal of Medicinal Chemistry|January 9, 2004
Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitorsQiang Lu, Ya-Ting Yang, Chang-Shi Chen, et al.
Bone Marrow Transplantation|March 1, 2005
Diffuse alveolar hemorrhage following gemtuzumab ozogamicinT S Lin, S L Penza, B R Avalos, et al.
Pageof 106

Showing results (401-410 of 1,058) with videos related to

Sort By:
Pageof 106
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activityJ C Byrd, C A White, B Link, et al.
Hematology/Oncology Clinics of North America|August 25, 2004
Antibody therapy for chronic lymphocytic leukemia: a promising new modalityThomas S Lin, Mollie Moran, Margaret Lucas, et al.
The Biochemical Journal|June 15, 1991
Differential mucin gene expression in human pancreatic and colon cancer cellsS Yonezawa, J C Byrd, R Dahiya, et al.
British Journal of Haematology|July 21, 2018
Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centreKerry A Rogers, Ying Huang, Emily Dotson, et al.
Molecular Cell|July 6, 2000
M6P/IGF2R imprinting evolution in mammalsJ K Killian, J C Byrd, J V Jirtle, et al.
Leukemia|April 4, 2017
PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatmentD Jones, J A Woyach, W Zhao, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
Examination of the Impact of Triazole Position within Linkers on Solubility and Lipophilicity of a CDK9 Degrader SeriesOluwatosin R Ayinde, Chia Sharpe, Emily Stahl, et al.
Cancer|May 15, 2018
Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemiaBarbara L Andersen, Neha Godiwala Goyal, David M Weiss, et al.
Journal of Medicinal Chemistry|January 9, 2004
Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitorsQiang Lu, Ya-Ting Yang, Chang-Shi Chen, et al.
Bone Marrow Transplantation|March 1, 2005
Diffuse alveolar hemorrhage following gemtuzumab ozogamicinT S Lin, S L Penza, B R Avalos, et al.
Pageof 106